The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Competing risks and the clinical community: irrelevance or ignorance?
Open accessAbstract
Life expectancy has dramatically increased in industrialized nations over the last 200 hundred years. The aging of populations carries over to clinical research and leads to an increasing representation of elderly and multimorbid individuals in study populations. Clinical research in these populations is complicated by the fact that individuals are likely to experience several potential disease endpoints that prevent some disease‐specific endpoint of interest from occurrence. Large developments in competing risks methodology have been achieved over the last decades, but we assume that recognition of competing risks in the clinical community is still marginal. It is the aim of this article to address translational aspects of competing risks to the clinical community. We describe clinical populations where competing risks issues may arise. We then discuss the importance of agreement between the competing risks methodology and the study aim, in particular the distinction between etiologic and prognostic research questions. In a review of 50 clinical studies performed in individuals susceptible to competing risks published in high‐impact clinical journals, we found competing risks issues in 70% of all articles. Better recognition of issues related to competing risks and of statistical methods that deal with competing risks in accordance with the aim of the study is needed. Copyright © 2011 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating
Steyerberg, E. W. (2019) · Statistics for Biology and Health · doi:10.1007/978-3-030-16399-0 · Cited by 3,281
Self-citationMortality Results from a Randomized Prostate-Cancer Screening Trial
Andriole, G. L., Crawford, E. D., Grubb, R. L., Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., Gelmann, E. P., Kvale, P. A., Reding, D. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810696 · Cited by 2,906
Gooley, T. A., Leisenring, W., Crowley, J., & Storer, B. E. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990330)18:6<695::aid-sim60>3.0.co;2-o · Cited by 2,688
Tutorial in biostatistics: competing risks and multi‐state models
Putter, H., Fiocco, M., & Geskus, R. B. (2007) · Statistics in Medicine · doi:10.1002/sim.2712 · Cited by 2,440
The number needed to treat: a clinically useful measure of treatment effect
Cook, R. J., & Sackett, D. L. (1995) · BMJ · doi:10.1136/bmj.310.6977.452 · Cited by 1,885
Modern Epidemiology 3rd edition
Rothman, K. J., Lash, T. L., & Greenland, S. (1986) · Cited by 1,735
Competing Risk Regression Models for Epidemiologic Data
Lau, B., Cole, S. R., & Gange, S. J. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp107 · Cited by 1,403
A nonidentifiability aspect of the problem of competing risks.
Tsiatis, A. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.1.20 · Cited by 862
Clinical Prediction Models: A Practical Approach to Development, Validation and Updating
Mann, C. J. H. (2009) · Kybernetes · doi:10.1108/k.2009.06738fae.002 · Cited by 783
Prognostic Models With Competing Risks: Methods and Application to Coronary Risk Prediction
Wolbers, M., Koller, M. T., Witteman, J. C. M., & Steyerberg, E. W. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181a39056 · Cited by 625
Self-citationThe Effect of Longevity on Spending for Acute and Long-Term Care
Spillman, B. C., & Lubitz, J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005113421906 · Cited by 417
Competing risks as a multi-state model
Andersen, P. K., Abildstrom, S. Z., & Rosthøj, S. (2002) · Statistical Methods in Medical Research · doi:10.1191/0962280202sm281ra · Cited by 319
Geskus, R. B. (2011) · Biometrics · doi:10.1111/j.1541-0420.2010.01420.x · Cited by 248
On criteria for evaluating models of absolute risk
Gail, M. H. (2005) · Biostatistics · doi:10.1093/biostatistics/kxi005 · Cited by 231
Racial and Ethnic Differences in End-of-Life Costs: Why Do Minorities Cost More Than Whites?
Hanchate, A., Kronman, A. C., Young-Xu, Y., Ash, A. S., & Emanuel, E. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.616 · Cited by 230
Varadhan, R., Weiss, C. O., Segal, J. B., Wu, A. W., Scharfstein, D., & Boyd, C. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181d99107 · Cited by 214
Simulating competing risks data in survival analysis
Beyersmann, J., Latouche, A., Buchholz, A., & Schumacher, M. (2009) · Statistics in Medicine · doi:10.1002/sim.3516 · Cited by 209
Wolkewitz, M., Vonberg, R. P., Grundmann, H., Beyersmann, J., Gastmeier, P., Bärwolff, S., Geffers, C., Behnke, M., Rüden, H., & Schumacher, M. C. (2008) · Critical Care · doi:10.1186/cc6852 · Cited by 144
Combined endpoints: can we use them?
Lubsen, J. C., & Kirwan, B. (2002) · Statistics in Medicine · doi:10.1002/sim.1300 · Cited by 107
Misspecified regression model for the subdistribution hazard of a competing risk
Latouche, A., Boisson, V., Chevret, S., & Porcher, R. (2006) · Statistics in Medicine · doi:10.1002/sim.2600 · Cited by 88
Beyersmann, J., Dettenkofer, M., Bertz, H., & Schumacher, M. C. (2007) · Statistics in Medicine · doi:10.1002/sim.3006 · Cited by 82
Proportional subdistribution hazards modeling offers a summary analysis, even if misspecified
Binder, N., Schumacher, M. C., & Beyersmann, J. (2010) · Statistics in Medicine · doi:10.1002/sim.3786 · Cited by 76
Molecular Markers and Death From Prostate Cancer
Concato, J., Jain, D., Uchio, E., Risch, H., Li, W. W., & Wells, C. K. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00005 · Cited by 55
Lubsen, J. C., Hoes, A. W., & Grobbee, D. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03215-3 · Cited by 55
Summary Measures of Population Health
Albrecht, G. L. (2006) · Sage eBooks · doi:10.4135/9781412950510.n758 · Cited by 50
Beyersmann, J., & Schumacher, M. (2006) · Statistics in Medicine · doi:10.1002/sim.2727 · Cited by 41
Estimates of clinically useful measures in competing risks survival analysis
Ambrogi, F., Biganzoli, E. M., & Boracchi, P. (2008) · Statistics in Medicine · doi:10.1002/sim.3455 · Cited by 32
Evaluating competing adverse and beneficial outcomes using a mixture model
Lau, B. M., Cole, S. R., Moore, R. D., & Gange, S. J. (2008) · Statistics in Medicine · doi:10.1002/sim.3293 · Cited by 24
Smit, C., Lindenburg, K., Geskus, R. B., et al. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01339.x · Cited by 22
Rosuvastatin in Patients with Elevated C-Reactive Protein
Gibbons, R. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmc082574 · Cited by 15
Parametric Estimation of Cumulative Incidence Functions for Interval Censored Competing Risks Data
Hudgens, M. G., Li, C., & Fine, J. P. (2011) · Cited by 4
Cited by
Introduction to the Analysis of Survival Data in the Presence of Competing Risks
Austin, P. C., Lee, D. S., & Fine, J. P. (2016) · Circulation · doi:10.1161/circulationaha.115.017719 · Cited by 2,653
Bahadoer, R. R., Dijkstra, E. A., van Etten, B., Marijnen, C. A. M., Putter, H., Kranenbarg, E. M.-K., Roodvoets, A. G. H., Nagtegaal, I. D., Beets-Tan, R. G. H., Blomqvist, L. K., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30555-6 · Cited by 1,693
Eyck, B. M., van Lanschot, J. J. B., Hulshof, M. C. C. M., van der Wilk, B. J., Shapiro, J., van Hagen, P., van Berge Henegouwen, M. I., Wijnhoven, B. P. L., van Laarhoven, H. W. M., Nieuwenhuijzen, G. A. P., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.03614 · Cited by 795
Self-citationData mining in clinical big data: the frequently used databases, steps, and methodological models
Wu, W.-T., Li, Y.-J., Feng, A.-Z., Li, L., Huang, T., Xu, A.-D., & Lyu, J. (2021) · Military Medical Research · doi:10.1186/s40779-021-00338-z · Cited by 505
Tegn, N., Abdelnoor, M., Aaberge, L., Endresen, K., Smith, P., Aakhus, S., Gjertsen, E., Dahl-Hofseth, O., Ranhoff, A. H., Gullestad, L., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01166-6 · Cited by 451
Metadata
- Authors
- Koller, M. T., Raatz, H., Steyerberg, E. W., & Wolbers, M.
- Venue
- Statistics in Medicine
- Publisher
- Wiley
- Published
- 2011-09-23
- Volume
- 31
- Issue
- 11-12
- Pages
- 1089-1097
- ISSN
- 0277-6715 (ISSN-L)
- 1097-0258
- OpenAlex
- W2150681691
- Cited by
- 302
- References
- 34
- FWCI
- 10.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.